| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Australia | 5 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | China | 4 | |
| #5 | Brazil | 3 | |
| #6 | Canada | 3 | |
| #7 | Israel | 3 | |
| #8 | Republic of Korea | 3 | |
| #9 | WIPO (World Intellectual Property Organization) | 3 | |
| #10 | Hungary | 1 | |
| #11 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Javitt Daniel C | 30 |
| #2 | Daniel C Javitt | 7 |
| #3 | Javitt Daniel | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2019054085A1 | Composition and method for treatment of depression and psychosis in humans | |
| KR20200020726A | Formulations for the treatment of post-traumatic stress disorder | |
| KR20200027501A | Treatment of depression with NMDA antagonist and D2 / 5HT2A or selective 5HT2A antagonist | |
| US2018263976A1 | Composition and method for treatment of depression and psychosis in humans |